Luxury skincare expansion: L’Oreal acquires majority stake in Medik8; announces 1 billion Euro deal
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
L'Oreal is set to acquire a majority stake in Medik8, a British skincare brand known for its vitamin A-focused products. This strategic move aims to bolster L'Oreal's presence in the thriving skincare market. The deal, valuing Medik8 at approximately €1 billion, will see Inflexion, the current majority holder, retain a minority share. What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
